The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,2,2-trifluoroacetate; 5-(2-azaniumyl-2-{[(1S,2S)-1-cyano-2-phenylcyclopropyl]carbamoyl}ethyl)-1,3-thiazol-3-ium ID: ALA1162478
PubChem CID: 46905616
Max Phase: Preclinical
Molecular Formula: C18H17F3N4O3S
Molecular Weight: 312.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#C[C@]1(NC(=O)C(N)Cc2cncs2)C[C@H]1c1ccccc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C16H16N4OS.C2HF3O2/c17-9-16(7-13(16)11-4-2-1-3-5-11)20-15(21)14(18)6-12-8-19-10-22-12;3-2(4,5)1(6)7/h1-5,8,10,13-14H,6-7,18H2,(H,20,21);(H,6,7)/t13-,14?,16+;/m0./s1
Standard InChI Key: AJGLLPBWNPILPL-ABULVECESA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
5.3160 -19.8407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3160 -20.6622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0288 -19.4300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6033 -19.4300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1374 -20.6622 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3160 -21.4836 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.4945 -20.6622 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.3650 -20.5503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6676 -20.9909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9394 -20.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7027 -21.8158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2420 -21.0517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9002 -19.7862 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4904 -20.6717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3120 -20.7048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9320 -19.9724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0099 -21.1489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9740 -21.9716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6710 -22.4114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4040 -22.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4355 -21.2013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7379 -20.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3456 -19.8572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2041 -19.0439 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0974 -20.9302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8397 -20.5635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4191 -21.1540 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0348 -21.8824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2208 -21.7460 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
2 5 1 0
2 6 1 0
2 7 1 0
20 21 1 0
12 14 1 0
21 22 2 0
22 17 1 0
15 14 1 0
14 23 1 6
16 15 1 0
23 24 3 0
14 16 1 0
8 25 1 0
25 26 2 0
9 11 1 0
8 9 1 0
15 17 1 1
26 27 1 0
27 28 2 0
28 29 1 0
29 25 1 0
10 12 1 0
17 18 2 0
18 19 1 0
10 13 2 0
19 20 2 0
9 10 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 312.40Molecular Weight (Monoisotopic): 312.1045AlogP: 1.58#Rotatable Bonds: 5Polar Surface Area: 91.80Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.20CX Basic pKa: 7.75CX LogP: 1.01CX LogD: 0.51Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.88Np Likeness Score: -0.24
References 1. Méthot N, Rubin J, Guay D, Beaulieu C, Ethier D, Reddy TJ, Riendeau D, Percival MD.. (2007) Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing., 282 (29): [PMID:17535802 ] [10.1074/jbc.m702615200 ]